Evolution and science, progress and change

Editorial

Frank C Detterbeck. Thorax. 2007 Aug.

. 2007 Aug;62(8):654-5.

doi: 10.1136/thx.2007.077594.

Abstract

Positron emission tomography in staging of intrathoracic lymph nodes in non‐small cell lung cancer

Competing interests: None.

Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG, Maddens S, Gosselin R, Van Maele G, van Meerbeeck JP, Kelles A. Tournoy KG, et al. Thorax. 2007 Aug;62(8):696-701. doi: 10.1136/thx.2006.072959. Thorax. 2007. PMID: 17687098 Free PMC article.

1. Tournoy K G, Maddens S, Gosselin R.et al Integrated FDG‐PET/CT does not make invasive staging of the intrathoracic lymph nodes in non‐small cell lung cancer redundant: a prospective study. Thorax 200762696–701. - PMC - PubMed
1. Detterbeck F, Jantz M, Wallace M.et alInvasive mediastinal staging of lung cancer: an ACCP evidence based clinical practice guideline, 2nd edn 2007 - PubMed
1. Serra M, Cirera L, Rami‐Porta R.et al Routine positron tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non‐small cell lung cancer (NSCLC). J Clin Oncol 200624371s
1. Cerfolio R J, Bryant A S, Ojha B.et al Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. Ann Thorac Surg 2005801207–1214. - PubMed
1. Pozo‐Rodriguez F, Martin de Nicolas J L, Sanchez‐Nistal M A.et al Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non‐small‐cell lung cancer. J Clin Oncol 2005238348–8356. - PubMed